James E Tisdale
Overview
Explore the profile of James E Tisdale including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
1412
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu X, Sung Y, Zhang L, Guo S, Yang M, Tisdale J, et al.
J Physiol
. 2025 Mar;
PMID: 40087827
β-3 adrenoceptor (AR) counteracts the β-1 and β-2 ARs and rescues the effects of excessive catecholamines. To test the hypothesis that a β-3 AR agonist (mirabegron) can reverse the effects...
2.
Aboshady O, Raffa J, Quinney S, Tisdale J, Overholser B
Clin Pharmacol Ther
. 2025 Feb;
PMID: 40012419
Pregnancy induces significant adaptations in the cardio-autonomic nervous system, with additional cardiac stress in preeclampsia potentially impacting ventricular repolarization. Despite the widespread use of QT-prolonging drugs during pregnancy, the extent...
3.
Huang C, Overholser B, Sowinski K, Jaynes H, Kovacs R, Tisdale J
JACC Adv
. 2024 Nov;
3(11):101354.
PMID: 39569032
Background: Heart failure (HF) with reduced ejection fraction (HFrEF) is a risk factor for drug-induced arrhythmias. It is unknown whether HF with preserved ejection fraction (HFpEF) also increases the risk....
4.
Alhurayri F, Jaynes H, Overholser B, Sowinski K, Kovacs R, Tisdale J
Int J Cardiol
. 2024 Oct;
418:132631.
PMID: 39393443
Background: Heart failure (HF) with preserved ejection fraction (HFpEF) is associated with enhanced response to drug-induced QT interval lengthening. We determined the influence of HFpEF on drug-induced lengthening of dispersion...
5.
Huang C, Overholser B, Sowinski K, Jaynes H, Kovacs R, Tisdale J
PLoS One
. 2024 Aug;
19(8):e0308999.
PMID: 39159176
Heart failure (HF) with reduced ejection fraction (HFrEF) is a risk factor for drug-induced QT interval prolongation. It is unknown if HF with preserved ejection fraction (HFpEF) is also associated...
6.
Batra A, Silka M, Borquez A, Cuneo B, Dechert B, Jaeggi E, et al.
Circulation
. 2024 Feb;
149(10):e937-e952.
PMID: 38314551
Disorders of the cardiac rhythm may occur in both the fetus and neonate. Because of the immature myocardium, the hemodynamic consequences of either bradyarrhythmias or tachyarrhythmias may be far more...
7.
Joglar J, Chung M, Armbruster A, Benjamin E, Chyou J, Cronin E, et al.
J Am Coll Cardiol
. 2023 Dec;
83(1):109-279.
PMID: 38043043
Aim: The "2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Patients With Atrial Fibrillation" provides recommendations to guide clinicians in the treatment of patients with atrial fibrillation. Methods: A...
8.
Joglar J, Chung M, Armbruster A, Benjamin E, Chyou J, Cronin E, et al.
Circulation
. 2023 Nov;
149(1):e1-e156.
PMID: 38033089
Aim: The "2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation" provides recommendations to guide clinicians in the treatment of patients with atrial fibrillation. Methods: A comprehensive literature...
9.
Carpenter J, Fagan R, Alzahrani M, Jaynes H, Tisdale J, Kovacs R, et al.
Menopause
. 2023 Aug;
30(10):1014-1021.
PMID: 37643379
Objective: The objective of this study is to describe peri- and postmenopausal women's experiences of palpitations (quality, frequency, severity, distress, duration and temporal pattern, aura, associated symptoms, and aggravating/alleviating factors)...
10.
Amarh E, Tisdale J, Overholser B
J Cardiovasc Pharmacol
. 2023 Jul;
82(3):212-220.
PMID: 37410999
Remdesivir, approved for the treatment of COVID-19, has been associated with heart-rate corrected QT interval (QTc) prolongation and torsade de pointes in case reports. However, data are conflicting regarding the...